1398
G. Chelucci et al. / Tetrahedron: Asymmetry 10 (1999) 1393–1400
4.2.2. (R)-2-[(4,5-Dihydro-4-phenyloxazol-2-yl)methyl]pyridine 2b
Reaction time: 96 h; 0.200 g (42%); 72–74°C; [α]D25 +10.3 (c 1.0, CHCl3); 1H NMR (CDCl3) δ: 8.58
(d, 1H, J=4.2 Hz), 7.62 (dt, 1H, J=7.5, 1.5 Hz), 7.40–7.17 (m, 7H), 5.21 (t, 1H, J=9.3 Hz), 4.63 (dd, 1H,
J=8.4, 9.9 Hz), 4.11 (t, 1H, J=8.7 Hz), 3.95 (s, 2H). Anal. calcd for C15H14N2O: C, 75.60; H, 5.93; N,
11.76. Found: C, 75.55; H, 5.98; N, 11.58.
4.3. General procedure for the preparation of 8-quinolinecarboxamides 6
A mixture of 8-quinolinecarboxylic acid methyl ester 5 (1 g, 5 mmol), the aminoalcohol (6.5 mmol)
and KCN (65 mg, 1 mmol) in toluene (15 ml) was heated under reflux for 24 h. The solvent was
evaporated under reduced pressure and the residue was purified by chromatography on a silica gel column
with the indicated eluent if not otherwise stated.
4.3.1. (S)-N-[2-Hydroxy-1-(1-methylethyl)ethyl]-8-quinolinecarboxamides 6a
Chromatographic eluent: benzene:acetone, 1:1; 1.23 g (95%); oil; 1H NMR (CDCl3) δ: 11.47 (d, 1H,
J=7.2 Hz), 8.74 (dd, 1H, J=4.2, 1.6 Hz), 8.70 (dd, 1H, J=7.4, 1.6 Hz), 8.08 (dd, 1H, J=8.2, 1.6 Hz), 7.75
(dd, 1H, J=8.2, 1.6 Hz), 7.43 (t, 1H, J=7.8 Hz), 7.30 (dd, 1H, J=8.4, 5.0 Hz), 4.15 (broad, 1H), 4.05
(m, 1H), 3.75 (m, 2H), 2.05 (m, 1H), 0.99 (d, 3H, J=3.8 Hz), 0.95 (d, 3H, J=3.8 Hz). Anal. calcd for
C15H18N2O2: C, 69.73; H, 7.03; N, 10.84. Found: C, 69.88; H, 7.12; N, 10.70.
4.3.2. (R)-N-[2-Hydroxy-1-phenylethyl]-8-quinolinecarboxamides 6b
In this case the residue was taken up with ethyl ether to give a white solid: 1.34 g (96%); mp
1
155–156°C. H NMR (CDCl3) δ: 12.12 (d, 1H, J=5.9 Hz), 8.89 (d, 1H, J=4.1 Hz), 8.82 (d, 1H, J=7.3
Hz), 8.30 (dd, 1H, J=8.3, 1.2 Hz), 7.98 (d, 1H, J=8.1 Hz), 7.46 (t, 1H, J=7.7 Hz), 7.55–7.12 (m, 6H),
5.49 (m, 1H), 4.04 (m, 2H), 3.58 (broad, 1H). Anal. calcd for C18H16N2O2: C, 73.94; H, 5.53; N, 9.58.
Found: C, 73.93; H, 5.68; N, 9.77.
4.3.3. (S)-N-[2-Hydroxy-1-(1,1-dimethylethyl)ethyl]-8-quinolinecarboxamides 6c
1
Chromatographic eluent: benzene:acetone, 8:2; 1.17 g (87%); mp 138–140°C; H NMR (CDCl3) δ:
11.70 (d, 1H, J=5.5 Hz), 8.93 (dd, 1H, J=4.3, 1.8 Hz), 8.86 (dd, 1H, J=7.4, 1.6 Hz), 8.33 (dd, 1H, J=8.3,
1.8 Hz), 7.98 (dd, 1H, J=8.1, 1.6 Hz), 7.70 (t, 1H, J=7.8 Hz), 7.52 (dd, 1H, J=8.3, 4.3 Hz), 4.15 (dt, 1H,
J=8.4, 1.8 Hz), 4.06 (dd, 1H, J=8.4, 1.4 Hz), 3.73 (m, 2H), 1.14 (s, 9H). Anal. calcd for C16H20N2O2: C,
70.55; H, 7.41; N, 10.29. Found: C, 70.63; H, 7.48; N, 10.27.
4.4. General procedure for the preparation of oxazolinylquinolines 3
Methanesulfonyl chloride (0.38 ml, 6.25 mmol) was added to a cold (0°C) solution of quinolinecarbox-
amides (5 mmol) and Et3N (1.39 ml, 10 mmol) in CH2Cl2 (20 ml). The reaction mixture was allowed to
warm to room temperature and stirring was continued overnight. The reaction mixture was then poured
into a saturated aqueous ammonium chloride solution, the organic layer was separated and the aqueous
layer was extracted with CH2Cl2. The combined organic phases were dried (Na2SO4) and concentrated
under reduced pressure. The residue was taken up with a 5% KOH methanolic solution (20 ml) and the
resulting solution was heated under reflux for 3 h. The solvent was evaporated and the residue was poured
into water and extracted with CH2Cl2. The organic phase was dried (Na2SO4) and concentrated under
reduced pressure. The residue was purified by chromatography on a silica gel column with the indicated
eluent.